Senior insider sale
SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$1.86M
18K shares
What this filing means
ALBERS JEFFREY W. plans to sell 18K shares of SPYRE THERAPEUTICS, INC. valued at approximately $1.86M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/7/2026ACC: 0001950047-26-007819
Director
Since Nov 2023
18K
Shares to sell
$1.86M
Approx. market value
18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Open Market Purchase
N/A
6/22/2022
18KTotal acquired18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/22/2022 | Open Market Purchase N/A | 18K | — |
| Total | 18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
18K
Market value
$1.86M
8/7/2026
Total
Units
18K
Value
$1.86M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/7/2026 | 18K | $1.86M | NASDAQ | Planned |
| Total | 18K | $1.86M | ||